CLINICAL_TRIALS
research
· 2020-06-04
Clinical Trial Update: Post-discharge Malaria Chemoprevention(PMC) Study [Phase 3]
Summary
A Phase 3 trial update on post-discharge malaria chemoprevention following severe malaria hospitalization is reported as completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Liverpool School of Tropical Medicine | Conditions: Malaria, Severe Anemia | Phase 3 | Status: COMPLETED